Infliximab optimisation in ulcerative colitis: Intensificated and deintensificated patients clinical outcome

被引：0
|
作者：
Fernandez-Salazar, L. [1 ]
Barrio, J. [2 ]
Legido, J. [3 ]
Munoz, C. [4 ]
Gonzalez, G. [1 ]
S-Ocana, R. [2 ]
Santos, F. [2 ]
Velayos, B. [1 ]
Gonzalez, J. M. [1 ]
机构：
[1] Hosp Clin Univ, Gastroenterol, Valladolid Acad, Spain
[2] Hosp Univ Rio Hortega, Gastroenterol, Valladolid, Spain
[3] Complejo Asistencial Segovia, Gastroenterol, Segovia Acad, Spain
[4] Hosp Virgen Salud, Gastroenterol, Toledo Acad, Spain
来源：
JOURNAL OF CROHNS & COLITIS | 2014年 / 8卷
关键词：
D O I：
10.1016/S1873-9946(14)60584-5
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P464
引用
收藏
页码：S260 / S260
页数：1
相关论文
共 50 条
  • [21] Infliximab in ulcerative colitis
    Levin, Avi
    Shibolet, Oren
    BIOLOGICS-TARGETS & THERAPY, 2008, 2 (03): : 379 - 388
  • [22] Infliximab and ulcerative colitis
    Cottone, M
    Mocciaro, F
    Modesto, I
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2006, 6 (04) : 401 - 408
  • [23] Infliximab in patients with steroid refractory ulcerative Colitis
    Boecker, U.
    GASTROENTEROLOGE, 2006, 1 (04): : 289 - 290
  • [24] The Effect of Infliximab on Patients with Ulcerative Colitis in Korea
    Seo, Hyun Il
    Park, Dong Il
    Kim, Tae Oh
    Kim, You Sun
    Lee, Suck-Ho
    Kim, Ji Won
    Kim, Jae Hak
    Shin, Jeong Eun
    INTESTINAL RESEARCH, 2014, 12 (03) : 214 - 220
  • [25] Validation of prior infliximab exposure and total colectomy outcome in patients with ulcerative colitis in Sweden
    Huang, Z.
    Hill, D.
    Bengtsson, C.
    Wang, M.
    Hakkarainen, K. M.
    Hellstrom, P. M.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I577 - I577
  • [26] Validation of prior infliximab exposure and total colectomy outcome in patients with ulcerative colitis in Sweden
    Huang, Z.
    Hill, D.
    Bengtsson, C.
    Wang, M.
    Hakkarainen, K. M.
    Hellstrom, P. M.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I577 - I577
  • [27] A Panel to Predict Long-term Outcome of Infliximab Therapy for Patients With Ulcerative Colitis
    Arias, Maria Theresa
    Casteele, Niels Vande
    Vermeire, Severine
    van Overstraeten, Anthony de Buck
    Billiet, Thomas
    Baert, Filip
    Wolthuis, Albert
    Van Assche, Gert
    Noman, Maja
    Hoffman, Ilse
    D'Hoore, Andre
    Gils, Ann
    Rutgeerts, Paul
    Ferrante, Marc
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2015, 13 (03) : 531 - 538
  • [28] Efficacy of infliximab in ulcerative colitis in a clinical practice setting
    Potack, Jonathan
    Abreu, Maria
    Ullman, Thomas
    Kornbluth, Asher
    George, James
    Legnani, Peter
    Weiss, Anthony
    Deconda, Deepthi
    Kissous-Hunt, Michele
    Mayer, Lloyd
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2006, 101 (09): : S459 - S459
  • [29] Review and clinical perspectives for the use of infliximab in ulcerative colitis
    Panaccione, Remo
    Fedorak, Richard N.
    Aumais, Guy
    Bernard, Edmond-Jean
    Bernstein, Charles N.
    Bitton, Alain
    Croitoru, Ken
    Dieleman, Levinus A.
    Enns, Robert
    Feagan, Brian G.
    Franchimont, Denis
    Greenberg, Gordon R.
    Griffiths, Anne-Marie
    Marshall, John K.
    Pare, Pierre
    Patel, Sunil
    Penner, Robert
    Render, Craig
    Seidman, Ernest
    Steinhart, Hillary
    CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2008, 22 (03) : 261 - 272
  • [30] Clinical outcome of adalimumab therapy in patients with ulcerative colitis previously treated with infliximab: a Danish single center cohort study
    Christensen, K. Risager
    Steenholdt, C.
    Brynskov, J.
    JOURNAL OF CROHNS & COLITIS, 2015, 9 : S231 - S231
12345